MD
Income statement / Annual
Last year (2023), Pediatrix Medical Group, Inc.'s total revenue was $1.99 B,
an increase of 1.15% from the previous year.
In 2023, Pediatrix Medical Group, Inc.'s net income was -$60.41 M.
See Pediatrix Medical Group, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$1.99 B
|
$1.97 B
|
$1.91 B
|
$1.73 B
|
$3.51 B
|
$3.65 B
|
$3.46 B
|
$3.18 B
|
$2.78 B
|
$2.44 B
|
| Cost of Revenue |
$1.57 B |
$1.50 B |
$1.40 B |
$1.28 B |
$2.62 B |
$2.66 B |
$2.46 B |
$2.15 B |
$1.85 B |
$1.63 B |
| Gross Profit |
$421.57 M |
$467.03 M |
$513.24 M |
$449.32 M |
$892.00 M |
$989.51 M |
$1.00 B |
$1.03 B |
$928.01 M |
$806.52 M |
| Gross Profit Ratio |
0.21 |
0.24 |
0.27 |
0.26 |
0.25 |
0.27 |
0.29 |
0.32 |
0.33 |
0.33 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$227.54 M
|
$231.40 M
|
$263.36 M
|
$248.95 M
|
$404.64 M
|
$432.38 M
|
$417.11 M
|
$372.57 M
|
$305.92 M
|
$247.53 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$227.54 M
|
$231.40 M
|
$263.36 M
|
$248.95 M
|
$404.64 M
|
$432.38 M
|
$417.11 M
|
$372.57 M
|
$305.92 M
|
$247.53 M
|
| Other Expenses |
$186.70 M |
$35.64 M |
$32.15 M |
$28.44 M |
$78.86 M |
$111.28 M |
$102.88 M |
$89.26 M |
$64.23 M |
$45.99 M |
| Operating Expenses |
$414.24 M |
$267.03 M |
$295.50 M |
$277.39 M |
$483.50 M |
$543.66 M |
$519.98 M |
$461.84 M |
$370.14 M |
$293.52 M |
| Cost And Expenses |
$1.99 B |
$1.77 B |
$1.69 B |
$1.56 B |
$3.11 B |
$3.20 B |
$2.98 B |
$2.61 B |
$2.22 B |
$1.93 B |
| Interest Income |
$0.00 |
$3.67 M |
$13.65 M |
$17.91 M |
$3.69 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$42.08 M |
$39.70 M |
$68.72 M |
$110.48 M |
$119.38 M |
$88.77 M |
$74.56 M |
$63.09 M |
$23.11 M |
$8.89 M |
| Depreciation &
Amortization |
$36.17 M
|
$35.64 M
|
$32.15 M
|
$28.44 M
|
$25.93 M
|
$83.83 M
|
$102.88 M
|
$89.26 M
|
$64.23 M
|
$45.99 M
|
| EBITDA |
$29.89 M
|
$235.64 M
|
$249.89 M
|
$200.37 M
|
$258.58 M
|
$527.69 M
|
$587.86 M
|
$660.95 M
|
$622.10 M
|
$558.99 M
|
| EBITDA Ratio |
0.01 |
0.12 |
0.13 |
0.12 |
0.14 |
0.15 |
0.17 |
0.21 |
0.22 |
0.23 |
| Operating Income Ratio
|
0
|
0.09
|
0.11
|
0.1
|
0.12
|
0.12
|
0.14
|
0.18
|
0.2
|
0.21
|
| Total Other
Income/Expenses Net |
-$55.68 M
|
-$91.32 M
|
-$67.69 M
|
-$90.98 M
|
-$112.97 M
|
$120.45 M
|
-$69.65 M
|
-$57.89 M
|
-$18.14 M
|
-$4.38 M
|
| Income Before Tax |
-$48.36 M |
$81.37 M |
$135.23 M |
$7.15 M |
-$1.24 B |
$368.84 M |
$410.42 M |
$513.80 M |
$539.73 M |
$508.62 M |
| Income Before Tax Ratio
|
-0.02
|
0.04
|
0.07
|
0
|
-0.35
|
0.1
|
0.12
|
0.16
|
0.19
|
0.21
|
| Income Tax Expense |
$12.05 M |
$18.81 M |
$27.24 M |
$16.73 M |
-$91.89 M |
$100.21 M |
$90.05 M |
$189.20 M |
$204.04 M |
$191.41 M |
| Net Income |
-$60.41 M |
$66.34 M |
$130.96 M |
-$9.58 M |
-$1.15 B |
$268.63 M |
$320.37 M |
$324.91 M |
$336.32 M |
$317.28 M |
| Net Income Ratio |
-0.03 |
0.03 |
0.07 |
-0.01 |
-0.33 |
0.07 |
0.09 |
0.1 |
0.12 |
0.13 |
| EPS |
-0.72 |
0.79 |
1.54 |
-0.11 |
-13.77 |
2.95 |
3.42 |
3.47 |
3.59 |
3.3 |
| EPS Diluted |
-0.73 |
0.79 |
1.53 |
-0.11 |
-13.77 |
2.93 |
3.42 |
3.47 |
3.58 |
3.18 |
| Weighted Average Shares
Out |
$84.02 M
|
$83.47 M
|
$84.83 M
|
$83.40 M
|
$83.50 M
|
$91.10 M
|
$92.43 M
|
$92.42 M
|
$93.74 M
|
$96.03 M
|
| Weighted Average Shares
Out Diluted |
$82.20 M
|
$84.12 M
|
$85.83 M
|
$83.40 M
|
$83.50 M
|
$91.61 M
|
$93.72 M
|
$93.72 M
|
$93.96 M
|
$99.89 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
